Drug intelligence / Profile preview

ecadotril

Development stage
Unknown
Lead developer
Bioprojet
Modality
Small Molecules
Administration
Oral
01

Overview

Ecadotril is the (S)-enantiomer of racecadotril. It functions as a neutral endopeptidase (NEP) inhibitor, specifically targeting enkephalinase (also known as neprilysin or neutral endopeptidase 24.11). By inhibiting this enzyme, ecadotril prevents the rapid degradation of endogenous enkephalins, which are naturally occurring opioid peptides. The prolonged action of enkephalins on delta-opioid receptors in the intestinal epithelium leads to a reduction in the secretion of water and electrolytes into the intestinal lumen. This antisecretory effect helps to alleviate diarrhea by decreasing stool volume and frequency without affecting normal intestinal motility. While primarily recognized for its antidiarrheal properties, some research has also explored its potential as an antihypertensive agent due to its role in modulating enkephalin levels, which can lead to vasodilation and blood pressure reduction.

Other names
Sinorphan(S)-Acetophanacetorphan, (S)-isomerEcadotriloecadotrilumRacecadotril (s)-Racecadotril (s)-formbenzyl 2-[[(2S)-2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetateN-[(S)-2-[(Acetylthio)methyl]-1-oxo-3-phenylpropyl]glycine benzyl esterGlycine, N-[(2S)-2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-, phenylmethyl esterN-((S)-alpha-(Mercaptomethyl)hydrocinnamoyl)glycine, benzyl ester, acetate (ester)N-(2-Acetylthiomethyl-1-oxo-3-phenylpropyl)glycine (S)(-)benzyl ester
02

Targets

NEP (Neutral Endopeptidase)

Beyond the preview

Go deeper on ecadotril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ecadotril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call